Brief: Corcept Therapeutics Q1 EPS USD 0.25 Vs. IBES Estimate USD 0.22
May 01 (Reuters) - Corcept Therapeutics Q1 net income USD 27.762 million vs. IBES estimate USD 25.3 million. * Q1 revenue USD 146.808 million vs. IBES estimate USD 141.2 million * Q1 cash & investments USD 451 million * outlook FY revenue USD 620-650 million
Recent news on Corcept Therapeutics Incorporated
See all newsDrugmaker Corcept seeks to bar ex-judge's views in Teva antitrust case
Live Markets: US earnings forecast jumps further after key reports this week
Live Markets: Who's next for the S&P 500? The clock is ticking
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Corcept Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary